Abstract
C1q nephropathy was originally described nearly 25 years ago by Jennette and Hipp. Since that time there have been a limited number of publications on C1q nephropathy, most of them in the pediatric literature. Despite reported incidences as high as 16% in some pediatric biopsy series, a consensus definition on the diagnosis of C1q nephropathy is lacking and its existence as a distinct clinical disease entity remains controversial. The purpose of this review is to discuss the biology of C1q in the context of mechanisms of C1q deposition, and to provide a detailed analysis of the published pediatric case series with a focus on the pathological criteria used to establish the diagnosis of C1q nephropathy as well as long-term outcomes in children.
Similar content being viewed by others
References
Peters DK, Williams DG (1972) Complement and the kidney. Proc R Soc Med 65:1095–1098
Neilson EG, Couser WG (2001) Immunologic renal diseases. Lippincott Williams & Wilkins, Nashville, p 1311
Turnberg D, Cook HT (2005) Complement and glomerulonephritis: new insights. Curr Opin Nephrol Hypertens 14:223–228
Quigg RJ (2003) Complement and the kidney. J Immunol 171:3319–3324
Seelen MA, Daha MR (2006) The role of complement in autoimmune renal disease. Autoimmunity 39:411–415
Fogo AB, Kashgarian M (2005) Diagnostic atlas of renal pathology. Saunders, Philadelphia, p 480
Jennette JC, Olson JL, Schwartz MM, Silva FG (2006) Heptinstall’s pathology of the kidney. Lippincott Williams & Wilkins, Baltimore
Smith RJ, Alexander J, Barlow PN, Botto M, Cassavant TL, Cook HT, de Cordoba SR, Hageman GS, Jokiranta TS, Kimberling WJ, Lambris JD, Lanning LD, Levidiotis V, Licht C, Lutz HU, Meri S, Pickering MC, Quigg RJ, Rops AL, Salant DJ, Sethi S, Thurman JM, Tully HF, Tully SP, van der Vlag J, Walker PD, Würzner R, Zipfel PF, Dense Deposit Disease Focus Group (2007) New approaches to the treatment of dense deposit disease. J Am Soc Nephrol 18:2447–2456
Servais A, Fremeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Grunfeld JP, Lesavre P, Noel LH, Fakhouri F (2007) Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with hemolytic uremic syndrome. J Med Genet 44:193–199
Habbig S, Mihatsch MJ, Heinen S, Beck B, Emmel M, Skerka C, Kirschfink M, Hoppe B, Zipfel PF, Licht C (2009) C3 deposition glomerulopathy due to a functional factor H defect. Kidney Int 75:1230–1234
Mii A, Shimizu A, Masuda Y, Fujita E, Aki K, Ishizaki M, Sato S, Griesemer A, Fukuda Y (2009) Current status and issues of C1q nephropathy. Clin Exp Nephrol 13:263–274
Vizjak A, Ferluga D, Rozic M, Hvala A, Lindic J, Levart TK, Jurcic V, Jennette JC (2008) Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol 19:2237–2244
Arlaud GJ, Gaboriaud C, Thielens NM, Rossi V (2002) Structural biology of C1. Biochem Soc Trans 30:1001–1006
Petry F, Hauptmann G, Goetz J, Grosshans E, Loos M (1997) Molecular basis of a new type of C1q-deficiency associated with a non-functional low molecular weight (LMW) C1q: parallels and differences to other known genetic C1q-defects. Immunopharmacology 38:189–201
Loos M, Martin H, Petry F (1989) The biosynthesis of C1q, the collagen-like and Fc recognizing molecule of the complement system. Behring Inst Mitt (84):32–41
Hoekzema R, Swaak AJ, Brouwer MC, van Rooijen A, Nieuwenhuys EJ, Hack CE (1990) Significance of low molecular weight C1q in systemic lupus erythematosus. Ann Rheum Dis 49:698–704
Muller W, Hanauske-Abel H, Loos M (1978) Biosynthesis of the first component of complement by human and guinea pig peritoneal macrophages: evidence for an independent production of the C1 subunits. J Immunol 121:1578–1584
Lu JH, Teh BK, Wang L, Wang YN, Tan YS, Lai MC, Reid KB (2008) The classical and regulatory functions of C1q in immunity and autoimmunity. Cell Mol Immunol 5:9–21
Ziccardi RJ, Tschopp J (1982) The dissociation properties of native C1. Biochem Biophys Res Commun 107:618–623
Villiers CL, Arlaud GJ, Painter RH, Colomb MG (1980) Calcium binding properties of the C1 subcomponents C1q, C1r and C1s. FEBS Lett 117:289–294
Augener W, Grey HM, Cooper NR, Muller-Eberhard HJ (1971) The reaction of monomeric and aggregated immunoglobulins with C1. Immunochemistry 8:1011–1020
Duncan AR, Winter G (1988) The binding site for C1q on IgG. Nature 332:738–740
Ziccardi RJ (1983) The first component of human complement (C1): activation and control. Springer Semin Immunopathol 6:213–230
Mevorach D, Mascarenhas JO, Gershov D, Elkon KB (1998) Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 188:2313–2320
Van den Dobbelsteen ME, van der Woude FJ, Schroeijers WE, Klar-Mohamad N, van Es LA, Daha MR (1993) C1Q, a subunit of the first component of complement, enhances the binding of aggregated IgG to rat renal mesangial cells. J Immunol 151:4315–4324
Sato T, van Dixhoorn MG, Heemskerk E, van Es LA, Daha MR (1997) C1q, a subunit of the first component of complement, enhances antibody-mediated apoptosis of cultured rat glomerular mesangial cells. Clin Exp Immunol 109:510–517
Cortes-Hernandez J, Fossati-Jimack L, Carugati A, Potter PK, Walport MJ, Cook HT, Botto M (2002) Murine glomerular mesangial cell uptake of apoptotic cells is inefficient and involves serum-mediated but complement-independent mechanisms. Clin Exp Immunol 130:459–466
Van den Dobbelsteen ME, van der Woude FJ, Schroeijers WE, Klar-Mohamad N, van Es LA, Daha MR (1996) Both IgG-and C1q-receptors play a role in the enhanced binding of IgG complexes to human mesangial cells. J Am Soc Nephrol 7:573–581
Trendelenburg M (2005) Antibodies against C1q in patients with systemic lupus erythematosus. Springer Semin Immunopathol 27:276–285
Ghai R, Waters P, Roumenina LT, Gadjeva M, Kojouharova MS, Reid KB, Sim RB, Kishore U (2007) C1q and its growing family. Immunobiology 212:253–266
Jennette JC, Hipp CG (1985) Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens. Am J Clin Pathol 83:415–420
Jennette JC, Hipp CG (1985) C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 6:103–110
Iskandar SS, Browning MC, Lorentz WB (1991) C1q nephropathy: a pediatric clinicopathologic study. Am J Kidney Dis 18:459–465
Lau KK, Gaber LW, Delos Santos NM, Wyatt RJ (2005) C1q nephropathy: features at presentation and outcome. Pediatr Nephrol 20:744–749
Kersnik Levart T, Kenda RB, Avgustin Cavic M, Ferluga D, Hvala A, Vizjak A (2005) C1Q nephropathy in children. Pediatr Nephrol 20:1756–1761
Fukuma Y, Hisano S, Segawa Y, Niimi K, Tsuru N, Kaku Y, Hatae K, Kiyoshi Y, Mitsudome A, Iwasaki H (2006) Clinicopathologic correlation of C1q nephropathy in children. Am J Kidney Dis 47:412–418
Wong CS, Fink CA, Baechle J, Harris AA, Staples AO, Brandt JR (2009) C1q nephropathy and minimal change nephrotic syndrome. Pediatr Nephrol 24:761–767
Roberti I, Baqi N, Vyas S, Kim DU (2009) A single-center study of C1q nephropathy in children. Pediatr Nephrol 24:77–82
Nishida M, Kawakatsu H, Okumura Y, Hamaoka K (2005) C1q nephropathy with asymptomatic urine abnormalities. Pediatr Nephrol 20:1669–1670
Kuwano M, Ito Y, Amamoto Y, Aida K (1993) A case of congenital nephrotic syndrome associated with positive C1q immunofluorescence. Pediatr Nephrol 7:452–454
Shappell SB, Myrthil G, Fogo A (1997) An adolescent with relapsing nephrotic syndrome: minimal-change disease versus focal-segmental glomerulosclerosis versus C1q nephropathy. Am J Kidney Dis 29:966–970
Nishida M, Kawakatsu H, Komatsu H, Ishiwari K, Tamai M, Sawada T (2000) Spontaneous improvement in a case of C1q nephropathy. Am J Kidney Dis 35:E22
Srivastava T, Chadha V, Taboada EM, Alon US (2000) C1q nephropathy presenting as rapidly progressive crescentic glomerulonephritis. Pediatr Nephrol 14:976–979
Ekim M, Ikinciogullari A, Berberoglu M, Tulunay O, Sencer H, Ozkaya N, Reisli I, Tumer N (2002) C1q nephropathy: a case with severe atopic dermatitis. Pediatr Nephrol 17:547–549
Roberti I, Sachdev S, Aronsky A, Kim DU (2006) C1q nephropathy in a child with a chromosome 13 deletion. Pediatr Nephrol 21:737–739
Krinsky CS, Harris A (2006) An 18-year-old woman with proteinuria and renal insufficiency. C1q nephropathy. Arch Pathol Lab Med 130:e53–e55
Hanevold C, Mian A, Dalton R (2006) C1q nephropathy in association with Gitelman syndrome: a case report. Pediatr Nephrol 21:1904–1908
Lim IS, Yun KW, Moon KC, Cheong HI (2007) Proteinuria in a boy with infectious mononucleosis, C1q nephropathy, and Dent’s disease. J Korean Med Sci 22:928–931
Kari JA, Jalalah SM (2008) C1q nephropathy in two young sisters. Pediatr Nephrol 23:487–490
Bitzan M, Ouahed JD, Krishnamoorthy P, Bernard C (2008) Rituximab treatment of collapsing C1q glomerulopathy: clinical and histopathological evolution. Pediatr Nephrol 23:1355–1361
Taggart L, Harris A, El-Dahr S, Iorember F (2010) C1q nephropathy in a child presenting with recurrent gross hematuria. Pediatr Nephrol 25:165–168
Jennette JC (2004) C1q nephropathy. In: Massry SG, Glassock RJ (eds) Textbook of nephrology. Lippincott, Williams & Wilkins, Philadelphia, pp 730–733
Davenport A, Maciver AG, Mackenzie JC (1992) C1q nephropathy: do C1q deposits have any prognostic significance in the nephrotic syndrome? Nephrol Dial Transplant 7:391–396
International Study of Kidney Diseases in Children (1978) Nephrotic syndrome in children: prediction of histology from clinical and laboratory characteristics at the time of diagnosis. Kidney Int 13:159–165
Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr (1997) Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8:769–776
Hodson EM, Craig JC, Willis NS (2005) Evidence-based management of steroid-sensitive nephrotic syndrome. Pediatr Nephrol 20:1523–1530
Hodson EM, Knight JF, Willis NS, Craig JC (2005) Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev (1):CD001533
Colquitt JL, Kirby J, Green C, Cooper K, Trompeter RS (2007) The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review. Health Technol Assess 11:1–93
Allen WR, Travis LB, Cavallo T, Brouhard BH, Cunningham RJ 3rd (1982) Immune deposits and mesangial hypercellularity in minimal change nephrotic syndrome: clinical relevance. J Pediatr 100:188–191
Southwest Pediatric Nephrology Study Group (1983) Childhood nephrotic syndrome associated with diffuse mesangial hypercellularity. A report of the Southwest Pediatric Nephrology Study Group. Kidney Int 24:87–94
Silverstein DM, Craver RD (2008) Mesangial hypercellularity in children: presenting features and outcomes. Pediatr Nephrol 23:921–928
Schnaper HW (2003) Idiopathic focal segmental glomerulosclerosis. Semin Nephrol 23:183–193
Gipson DS, Gibson K, Gipson PE, Watkins S, Moxey-Mims M (2007) Therapeutic approach to FSGS in children. Pediatr Nephrol 22:28–36
Hodson EM, Habashy D, Craig JC (2006) Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Cochrane Database Syst Rev (2):CD003594
Wehrmann M, Bohle A, Held H, Schumm G, Kendziorra H, Pressler H (1990) Longterm prognosis of focal sclerosing glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes. Clin Nephrol 33:115–122
Paik KH, Lee BH, Cho HY, Kang HG, Ha IS, Cheong HI, Jin DK, Moon KC, Choi Y (2007) Primary focal segmental glomerular sclerosis in children: clinical course and prognosis. Pediatr Nephrol 22:389–395
Abeyagunawardena AS, Sebire NJ, Risdon RA, Dillon MJ, Rees L, Van’t Hoff W, Kumarasiri PV, Trompeter RS (2007) Predictors of long-term outcome of children with idiopathic focal segmental glomerulosclerosis. Pediatr Nephrol 22:215–221
Rifai A, Mannik M (1983) Clearance kinetics and fate of mouse IgA immune complexes prepared with monomeric or dimeric IgA. J Immunol 130:1826–1832
Rifai A, Millard K (1985) Glomerular deposition of immune complexes prepared with monomeric or polymeric IgA. Clin Exp Immunol 60:363–368
Emancipator SN (1988) Experimental models of IgA nephropathy. Am J Kidney Dis 12:415–419
Gomez-Guerrero C, Lopez-Armada MJ, Gonzalez E, Egido J (1994) Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation. J Immunol 153:5247–5255
Chao TK, Rifai A, Ka SM, Yang SM, Shui HA, Lin YF, Sytwu HK, Lee WH, Kung JT, Chen A (2006) The endogenous immune response modulates the course of IgA-immune complex mediated nephropathy. Kidney Int 70:283–297
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wenderfer, S.E., Swinford, R.D. & Braun, M.C. C1q nephropathy in the pediatric population: pathology and pathogenesis. Pediatr Nephrol 25, 1385–1396 (2010). https://doi.org/10.1007/s00467-009-1429-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-009-1429-x